JP2021519324A5 - - Google Patents

Info

Publication number
JP2021519324A5
JP2021519324A5 JP2020552322A JP2020552322A JP2021519324A5 JP 2021519324 A5 JP2021519324 A5 JP 2021519324A5 JP 2020552322 A JP2020552322 A JP 2020552322A JP 2020552322 A JP2020552322 A JP 2020552322A JP 2021519324 A5 JP2021519324 A5 JP 2021519324A5
Authority
JP
Japan
Prior art keywords
microscale
bubbles
nanoscale
nanoscale droplets
droplets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020552322A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021519324A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/024713 external-priority patent/WO2019191518A1/en
Publication of JP2021519324A publication Critical patent/JP2021519324A/ja
Publication of JP2021519324A5 publication Critical patent/JP2021519324A5/ja
Priority to JP2024169768A priority Critical patent/JP2025000828A/ja
Pending legal-status Critical Current

Links

JP2020552322A 2018-03-29 2019-03-28 アルツハイマー病を検出および治療する組成物および方法 Pending JP2021519324A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024169768A JP2025000828A (ja) 2018-03-29 2024-09-30 アルツハイマー病を検出および治療する組成物および方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862650239P 2018-03-29 2018-03-29
US62/650,239 2018-03-29
PCT/US2019/024713 WO2019191518A1 (en) 2018-03-29 2019-03-28 Compositions and methods of detecting and treating alzheimer's disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024169768A Division JP2025000828A (ja) 2018-03-29 2024-09-30 アルツハイマー病を検出および治療する組成物および方法

Publications (2)

Publication Number Publication Date
JP2021519324A JP2021519324A (ja) 2021-08-10
JP2021519324A5 true JP2021519324A5 (enExample) 2022-03-31

Family

ID=68060802

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020552322A Pending JP2021519324A (ja) 2018-03-29 2019-03-28 アルツハイマー病を検出および治療する組成物および方法
JP2024169768A Pending JP2025000828A (ja) 2018-03-29 2024-09-30 アルツハイマー病を検出および治療する組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024169768A Pending JP2025000828A (ja) 2018-03-29 2024-09-30 アルツハイマー病を検出および治療する組成物および方法

Country Status (8)

Country Link
US (1) US20210008204A1 (enExample)
EP (1) EP3773500A4 (enExample)
JP (2) JP2021519324A (enExample)
KR (1) KR20210018789A (enExample)
CN (2) CN116173238A (enExample)
AU (2) AU2019243579B2 (enExample)
CA (1) CA3094377A1 (enExample)
WO (1) WO2019191518A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3658172A4 (en) 2017-07-25 2021-05-05 TrueBinding, Inc. TREATING CANCER BY BLOCKING THE INTERACTION OF TIM-3 AND HIS LIGAND
AU2019243579B2 (en) * 2018-03-29 2024-05-09 Microvascular Therapeutics LLC Compositions and methods of detecting and treating Alzheimer's disease
CN113711036B (zh) 2019-01-30 2025-03-18 真和制药有限公司 抗gal3抗体及其用途
KR102490837B1 (ko) * 2020-03-19 2023-01-19 포항공과대학교 산학협력단 뇌-혈관 장벽 투과성을 증가시키는 방법
CN116157151A (zh) 2020-05-26 2023-05-23 真和制药有限公司 通过阻断半乳凝素-3治疗炎性疾病的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9712683A (pt) * 1996-10-28 1999-10-19 Nyomed Imaging A S Agente de diagnóstico e/ou terapeuticamente ativo alvejável, formulação combinada, processo para preparação e uso do mesmo, formulação combinada, e processos para gerar imagens intensificadas de um corpo animal humano ou não-humano e para investigação in vitro de alvejamento por um agente.
US6090800A (en) * 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
US8877236B2 (en) * 2012-06-28 2014-11-04 Universita Degli Studi Di Milano-Bicocca Liposomes active in-vivo on neurodegenerative diseases
CN107106692B (zh) * 2014-06-12 2021-01-05 埃文·C·昂格尔 磷脂组合物和微囊及使用磷脂组合物和微囊形成的乳剂
KR102409017B1 (ko) * 2014-10-08 2022-06-16 텍사스 칠드런스 하스피탈 리포좀을 이용한 아밀로이드 플라크의 mri 영상화
AU2019243579B2 (en) * 2018-03-29 2024-05-09 Microvascular Therapeutics LLC Compositions and methods of detecting and treating Alzheimer's disease

Similar Documents

Publication Publication Date Title
Lee et al. Stimuli‐responsive liposomes for drug delivery
ES2225878T3 (es) Nuevas composiciones de lipidos y materiales estabilizadores.
ES2531732T3 (es) Montaje de microvesícula rellena de gas para imagenología de contraste
CN1897978B (zh) 具有用于反差成像的活性组分的充气微囊组件
JP2007515470A5 (enExample)
US20040115192A1 (en) Ligand-targeted emulsions carrying bioactive agents
JP7795461B2 (ja) ポリ乳酸塩を含む薬物送達用ナノ粒子組成物製造用キット
JP2017517533A (ja) リン脂質組成並びにそれを用いて形成されたマイクロバブルおよびエマルジョン
JP2002512206A5 (enExample)
JP2006516539A (ja) 物質を血液−脳関門を渡って輸送するための人工低密度リポタンパク質キャリア
JP6803839B2 (ja) 標的化されたガス入りの微小胞の製剤
Antimisiaris et al. Liposomes and drug delivery
CN112384202B (zh) 用于检测和治疗阿尔茨海默病的组合物及方法
CN107708742A (zh) 诊断治疗用气泡制剂(tb)及其使用方法
JP2023518944A5 (enExample)
CN110064057B (zh) 一种透过血脑屏障的载药纳米颗粒的制备及其联合聚焦超声靶向微泡破坏技术的应用
US10010630B2 (en) Gas-filled microvesicles
JP5787323B2 (ja) 脂質膜構造体
ES2347119A1 (es) Nanocapsulas de poliarginina.
ES2640060T3 (es) Proceso para producir una partícula fina revestida
ES2698565B2 (es) Procedimiento para la elaboración de nanopartículas lipídicas, y nanopartículas lipídicas con los macrófagos cerebrales como células diana
JP6384863B2 (ja) 脂質膜構造体
AU2022266501B2 (en) Composition for drug delivery comprising nanoparticles not containing amphiphilic polymer
WO2005092389A1 (ja) 複合粒子および被覆複合粒子
WO2017222042A1 (ja) 眼用医薬組成物